TELA Bio (TELA) News Today $2.99 0.00 (0.00%) (As of 11:39 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period The past five years for TELA Bio (NASDAQ:TELA) investors has not been profitableDecember 1 at 12:41 PM | uk.finance.yahoo.comTELA Bio, Inc. (NASDAQ:TELA) Short Interest Down 29.8% in NovemberTELA Bio, Inc. (NASDAQ:TELA - Get Free Report) was the recipient of a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 335,900 shares, a decline of 29.8% from the October 31st total of 478,700 shares. Based on an average trading volume of 223,100 shares, the days-to-cover ratio is presently 1.5 days.November 29, 2024 | marketbeat.comTELA Bio Set for Growth with Strategic Enhancements and Financial ImprovementsNovember 23, 2024 | markets.businessinsider.comTELA Bio Set to Unveil Innovations at Piper Sandler’s Premier Healthcare Conference!November 21, 2024 | msn.comTELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare ConferenceNovember 20, 2024 | markets.businessinsider.comTELA Bio to Participate in Piper Sandler's 36th Annual Healthcare ConferenceNovember 19, 2024 | globenewswire.comTELA Bio’s Strong Financial Performance and Strategic Positioning Justify Buy RatingNovember 13, 2024 | markets.businessinsider.comTELA Bio, Inc. (NASDAQ:TELA) Sees Large Drop in Short InterestTELA Bio, Inc. (NASDAQ:TELA - Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 31st, there was short interest totalling 478,700 shares, a decline of 68.9% from the October 15th total of 1,540,000 shares. Based on an average daily volume of 258,700 shares, the days-to-cover ratio is presently 1.9 days.November 12, 2024 | marketbeat.comTELA Bio Third Quarter 2024 Earnings: EPS Beats ExpectationsNovember 11, 2024 | finance.yahoo.comQ3 2024 TELA Bio Inc Earnings CallNovember 10, 2024 | finance.yahoo.comTELA Bio Reports Strong Revenue Growth in Q3 2024November 10, 2024 | msn.comTela Bio price target lowered to $5 from $8 at Piper SandlerNovember 10, 2024 | markets.businessinsider.comTELA Bio, Inc. (TELA) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comTELA Bio (NASDAQ:TELA) Price Target Lowered to $5.00 at Piper SandlerPiper Sandler decreased their target price on TELA Bio from $8.00 to $5.00 and set an "overweight" rating for the company in a research report on Friday.November 8, 2024 | marketbeat.comTELA Bio Reports Third Quarter 2024 Financial ResultsNovember 7, 2024 | markets.businessinsider.comWhat To Expect From TELA Bio Inc (TELA) Q3 2024 EarningsNovember 6, 2024 | finance.yahoo.comTELA Bio Announces Inducement Grants of Restricted Stock Units to New EmployeesNovember 3, 2024 | msn.comTELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)November 1, 2024 | globenewswire.comMalvern Medtech Company Aims to Raise $40 Million in Upcoming Stock SaleOctober 28, 2024 | msn.comAntony Koblish Bought 42% More Shares In TELA BioOctober 27, 2024 | finance.yahoo.comTela Bio Prices $40 Mln Public Offering At $2.25/shareOctober 25, 2024 | markets.businessinsider.comTela Bio expects to raise $40M this week from stock and warrant saleOctober 25, 2024 | bizjournals.comInsider Buying: TELA Bio, Inc. (NASDAQ:TELA) Insider Acquires 6,666 Shares of StockOctober 25, 2024 | insidertrades.comTELA Bio, Inc. (NASDAQ:TELA) Insider Purchases $14,998.50 in StockTELA Bio, Inc. (NASDAQ:TELA - Get Free Report) insider Gregory A. Firestone acquired 6,666 shares of the stock in a transaction dated Thursday, October 24th. The shares were acquired at an average cost of $2.25 per share, with a total value of $14,998.50. Following the completion of the transaction, the insider now owns 57,279 shares in the company, valued at approximately $128,877.75. This represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.October 24, 2024 | marketbeat.comTELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional SharesOctober 24, 2024 | globenewswire.comTELA Bio (TELA) Gets a Buy from Piper SandlerOctober 24, 2024 | markets.businessinsider.comTela Bio 12M share Spot Secondary priced at $2.25October 24, 2024 | markets.businessinsider.comTELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded WarrantsOctober 23, 2024 | globenewswire.comTELA Bio (NASDAQ:TELA) Stock, Short Interest ReportOctober 23, 2024 | benzinga.comTELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsOctober 22, 2024 | globenewswire.comGet Ready: TELA Bio to Unveil Q3 2024 Financial Results on November 7!October 18, 2024 | msn.comTELA Bio to Announce Third Quarter 2024 Financial ResultsOctober 17, 2024 | globenewswire.comTesla reveals 20 Cybercabs at We, Robot event, says you’ll be able to buy one for less than $30,000October 11, 2024 | msn.comCanaccord maintains Buy rating on TELA Bio sharesOctober 6, 2024 | investing.comDemystifying TELA Bio: Insights From 6 Analyst ReviewsOctober 6, 2024 | benzinga.comCanaccord Genuity Group Reiterates Buy Rating for TELA Bio (NASDAQ:TELA)Canaccord Genuity Group reaffirmed a "buy" rating and issued a $12.00 price objective on shares of TELA Bio in a research report on Friday.October 4, 2024 | marketbeat.comOrbimed Advisors LLC Reduces Stake in TELA Bio IncOctober 2, 2024 | finance.yahoo.comNantahala Capital Management LLC Buys 1,347,801 Shares of TELA Bio, Inc. (NASDAQ:TELA)Nantahala Capital Management LLC boosted its stake in shares of TELA Bio, Inc. (NASDAQ:TELA - Free Report) by 122.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,445,667 shares of the company's stocOctober 1, 2024 | marketbeat.comParadigm Capital Management Inc. NY Boosts Stock Holdings in TELA Bio, Inc. (NASDAQ:TELA)Paradigm Capital Management Inc. NY increased its stake in TELA Bio, Inc. (NASDAQ:TELA - Free Report) by 143.8% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,256,200 shares of theSeptember 24, 2024 | marketbeat.comAIGH Capital Management LLC Grows Holdings in TELA Bio, Inc. (NASDAQ:TELA)AIGH Capital Management LLC raised its position in shares of TELA Bio, Inc. (NASDAQ:TELA - Free Report) by 17.1% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,656,655 shares of the company's stock after acquirSeptember 9, 2024 | marketbeat.comCatalyst Watch: Nvidia's blockbuster earnings, CrowdStrike on the hot seat, and PCE inflation watchAugust 24, 2024 | msn.comINTERNATIONAL COLLABORATION AIMS TO COMBAT DIABETES EPIDEMIC IN THE SOUTH PACIFICAugust 21, 2024 | finance.yahoo.comShort Interest in TELA Bio, Inc. (NASDAQ:TELA) Increases By 21.1%TELA Bio, Inc. (NASDAQ:TELA - Get Free Report) saw a large growth in short interest during the month of July. As of July 31st, there was short interest totalling 2,350,000 shares, a growth of 21.1% from the July 15th total of 1,940,000 shares. Based on an average daily volume of 203,600 shares, the short-interest ratio is presently 11.5 days.August 16, 2024 | marketbeat.comTELA Bio, Inc.: TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue GuidanceAugust 15, 2024 | finanznachrichten.deOptimistic Buy Rating for TELA Bio Amidst Recovery and Strong Growth ProspectsAugust 14, 2024 | markets.businessinsider.comTELA Bio, Inc. (NASDAQ:TELA) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | msn.comLake Street Capital Trims TELA Bio (NASDAQ:TELA) Target Price to $8.00Lake Street Capital decreased their price objective on shares of TELA Bio from $14.00 to $8.00 and set a "buy" rating for the company in a research report on Tuesday.August 13, 2024 | marketbeat.comTELA Bio (NASDAQ:TELA) Releases Earnings Results, Misses Expectations By $0.06 EPSTELA Bio (NASDAQ:TELA - Get Free Report) issued its earnings results on Monday. The company reported ($0.51) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.45) by ($0.06). TELA Bio had a negative return on equity of 155.26% and a negative net margin of 63.82%. The firm had revenue of $16.09 million for the quarter, compared to analysts' expectations of $19.00 million. During the same quarter in the previous year, the firm posted ($0.46) EPS.August 13, 2024 | marketbeat.comTELA Bio, Inc. (TELA) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | seekingalpha.comTELA Stock Earnings: TELA Bio Misses EPS, Misses Revenue for Q2 2024August 12, 2024 | investorplace.com Get TELA Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter. Email Address This Crisis Could Be Worse Than 2008 (Ad)Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America is teetering on the edge of a collapse unlike anything we've seen. In my new book, "Midnight in America," I expose the hidden deals between Washington and Wall Street. TELA Media Mentions By Week TELA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TELA News Sentiment▼1.190.87▲Average Medical News Sentiment TELA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TELA Articles This Week▼42▲TELA Articles Average Week Get TELA Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Tactile Systems Technology News Today ZimVie News Today Delcath Systems News Today CVRx News Today Nano-X Imaging News Today NeuroPace News Today AVITA Medical News Today ClearPoint Neuro News Today Sanara MedTech News Today Perspective Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TELA) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TELA Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TELA Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
